HealthPolitics

Opinion: How states can resist the potential Trump vaccine shortages

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 14/10/2026, 12:27:27 UTC.

Briefings

A new paper argues that state-level policymakers can intervene to produce vaccines and prevent shortages, countering claims that the Trump administration's potential changes to the Vaccine Injury Compensation Program will cause domestic supply failures. The evidence suggests skepticism has moved to federal levels, but the paper asserts state action is a viable alternative to federal policy shifts.

Key points

• The Trump administration is reportedly considering changes to the Vaccine Injury Compensation Program, a policy that has protected domestic vaccine supply for 40 years.
• State-level policymakers can step in to directly produce vaccines to prevent shortages and harm to the American people.

Context

Vaccine skepticism has worked its way from the fringes of the public to the highest levels of the federal government, prompting concerns about potential supply disruptions.

Limitations

The evidence is untrusted data; the paper is a preprint and does not contain author names, specific dates beyond the publication date, or causal claims about the effectiveness of state interventions.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 25/10/2026, 03:58:44 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeigblijbccvhnktofgdr5ihwgoewxhr6iqgxdtrbxhfdvcv5z7k2uu